Heterogeneity of Autism Characteristics in Genetic Syndromes: Key Considerations for Assessment and Support.

Lauren Jenner, Caroline Richards, Rachel Howard, Joanna Moss
Author Information
  1. Lauren Jenner: School of Psychology, University of Surrey, Guildford, England.
  2. Caroline Richards: School of Psychology, University of Birmingham, Birmingham, UK. ORCID
  3. Rachel Howard: School of Psychology, University of Surrey, Guildford, England.
  4. Joanna Moss: School of Psychology, University of Surrey, Guildford, England.

Abstract

Purpose of Review: Elevated prevalence of autism characteristics is reported in genetic syndromes associated with intellectual disability. This review summarises recent evidence on the behavioural heterogeneity of autism in the following syndromes: Fragile X, Cornelia de Lange, Williams, Prader-Willi, Angelman, Down, Smith-Magenis, and tuberous sclerosis complex. Key considerations for assessment and support are discussed.
Recent Findings: The profile and developmental trajectory of autism-related behaviour in these syndromes indicate some degree of syndrome specificity which may interact with broader behavioural phenotypes (e.g. hypersociability), intellectual disability, and mental health (e.g. anxiety). Genetic subtype and co-occurring epilepsy within syndromes contribute to increased significance of autism characteristics. Autism-related strengths and challenges are likely to be overlooked or misunderstood using existing screening/diagnostic tools and criteria, which lack sensitivity and specificity within these populations.
Summary: Autism characteristics are highly heterogeneous across genetic syndromes and often distinguishable from non-syndromic autism. Autism diagnostic assessment practices in this population should be tailored to specific syndromes. Service provisions must begin to prioritise needs-led support.

Keywords

References

  1. J Autism Dev Disord. 2022 May;52(5):1942-1955 [PMID: 34043129]
  2. Dev Med Child Neurol. 2017 Mar;59(3):276-283 [PMID: 27503703]
  3. J Neurodev Disord. 2021 Jun 21;13(1):25 [PMID: 34148559]
  4. Genet Med. 2010 Jul;12(7):385-95 [PMID: 20445456]
  5. Am J Speech Lang Pathol. 2021 Jan 27;30(1):34-46 [PMID: 33316160]
  6. Mol Autism. 2018 Jan 8;9:1 [PMID: 29321841]
  7. Front Behav Neurosci. 2021 Feb 16;15:618271 [PMID: 33664655]
  8. Pediatr Neurol. 2021 Jan;114:21-25 [PMID: 33189026]
  9. Mol Autism. 2014 Feb 11;5(1):11 [PMID: 24517317]
  10. Dev Psychopathol. 2020 Oct;32(4):1335-1352 [PMID: 33161907]
  11. Res Dev Disabil. 2019 Jun;89:83-93 [PMID: 30959431]
  12. Am J Intellect Dev Disabil. 2021 Sep 1;126(5):409-420 [PMID: 34428269]
  13. J Autism Dev Disord. 2016 Jun;46(6):2148-2159 [PMID: 26983920]
  14. J Neurodev Disord. 2017 Jun 5;9:18 [PMID: 28592997]
  15. Curr Opin Psychiatry. 2017 Mar;30(2):92-96 [PMID: 28125439]
  16. Autism. 2016 May;20(4):442-62 [PMID: 26134030]
  17. Orphanet J Rare Dis. 2015 Aug 27;10:105 [PMID: 26306707]
  18. Am J Med Genet A. 2014 Jun;164A(6):1400-10 [PMID: 24718998]
  19. J Autism Dev Disord. 2018 Mar;48(3):796-808 [PMID: 29124472]
  20. Res Autism Spectr Disord. 2017 Aug;40:1-12 [PMID: 29170682]
  21. Autism Res. 2017 Dec;10(12):1981-1990 [PMID: 28801991]
  22. Nat Neurosci. 2016 Apr 26;19(6):647-655 [PMID: 29323671]
  23. Pediatrics. 2017 Jun;139(Suppl 3):S194-S206 [PMID: 28814540]
  24. Behav Genet. 2011 May;41(3):437-44 [PMID: 21191642]
  25. Res Dev Disabil. 2022 Jul;126:104235 [PMID: 35468572]
  26. J Autism Dev Disord. 2000 Jun;30(3):205-23 [PMID: 11055457]
  27. J Autism Dev Disord. 2015 Aug;45(8):2624-7 [PMID: 25749713]
  28. J Autism Dev Disord. 2017 Jan;47(1):135-143 [PMID: 27771801]
  29. Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):135-49 [PMID: 25989505]
  30. Mol Autism. 2018 Jan 8;9:2 [PMID: 29340132]
  31. J Clin Psychiatry. 2009 Jul;70(7):967-74 [PMID: 19497248]
  32. J Autism Dev Disord. 2020 Nov;50(11):4001-4010 [PMID: 32189229]
  33. J Autism Dev Disord. 2019 Sep;49(9):3543-3556 [PMID: 31124029]
  34. J Intellect Disabil Res. 2019 Oct;63(10):1234-1247 [PMID: 31134691]
  35. Pediatr Ann. 2017 Apr 1;46(4):e166-e171 [PMID: 28414398]
  36. J Autism Dev Disord. 2015 Sep;45(9):2816-32 [PMID: 25904201]
  37. Genes (Basel). 2022 Feb 11;13(2): [PMID: 35205380]
  38. J Autism Dev Disord. 2018 Sep;48(9):3037-3050 [PMID: 29671106]
  39. Neurology. 2016 Aug 23;87(8):766-72 [PMID: 27440144]
  40. Dev Med Child Neurol. 2019 Nov;61(11):1266-1274 [PMID: 31074506]
  41. J Child Psychol Psychiatry. 2006 Jun;47(6):591-601 [PMID: 16712636]
  42. Autism Res. 2021 Sep;14(9):1986-1995 [PMID: 34110083]
  43. Dev Psychol. 2013 Jan;49(1):59-71 [PMID: 22545843]
  44. ASN Neuro. 2018 Jan-Dec;10:1759091418801092 [PMID: 30231625]
  45. Am J Med Genet A. 2022 Sep;188(9):2536-2554 [PMID: 35730128]
  46. Curr Opin Psychiatry. 2021 Mar 1;34(2):112-117 [PMID: 33278154]
  47. Neurology. 2017 Apr 4;88(14):1371-1380 [PMID: 28275086]
  48. J Intellect Disabil. 2021 Dec;25(4):429-440 [PMID: 31984836]
  49. Am J Intellect Dev Disabil. 2013 Jul;118(4):262-83 [PMID: 23937369]
  50. Curr Neurol Neurosci Rep. 2018 Oct 17;18(12):94 [PMID: 30328520]
  51. J Child Neurol. 2008 May;23(5):520-5 [PMID: 18160549]
  52. J Atten Disord. 2019 Jan;23(2):181-188 [PMID: 25731183]
  53. J Clin Med. 2019 Jun 03;8(6): [PMID: 31163675]
  54. J Intellect Disabil Res. 2017 Jan;61(1):75-82 [PMID: 27868264]
  55. PLoS Genet. 2006 Mar;2(3):e50 [PMID: 16596169]
  56. J Autism Dev Disord. 2009 Apr;39(4):572-88 [PMID: 19037716]
  57. Dev Med Child Neurol. 2020 Mar;62(3):322-329 [PMID: 31538337]
  58. Neurosci Biobehav Rev. 2017 Jan;72:153-167 [PMID: 27836461]
  59. J Dev Behav Pediatr. 2020 Apr;41(3):172-179 [PMID: 31599791]
  60. Lancet Psychiatry. 2015 Oct;2(10):909-16 [PMID: 26341300]
  61. Epilepsy Behav. 2020 Feb;103(Pt A):106844 [PMID: 31864941]
  62. J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):921-33 [PMID: 20732628]
  63. J Neurodev Disord. 2016 Dec 30;8:47 [PMID: 28050218]
  64. J Autism Dev Disord. 2007 Aug;37(7):1394-5 [PMID: 17410415]
  65. Isr J Psychiatry Relat Sci. 2010;47(2):125-31 [PMID: 20733255]
  66. Autism. 2012 Sep;16(5):487-97 [PMID: 21690082]
  67. Dev Med Child Neurol. 2022 Oct;64(10):1214-1229 [PMID: 35724267]
  68. Front Neurol. 2020 Aug 11;11:639 [PMID: 32849171]
  69. J Autism Dev Disord. 2018 Nov;48(11):3958-3964 [PMID: 29948532]
  70. J Intellect Disabil Res. 2016 May;60(5):512-22 [PMID: 27120992]
  71. J Autism Dev Disord. 2019 Nov;49(11):4441-4454 [PMID: 31388797]
  72. J Autism Dev Disord. 2020 Jan;50(1):127-144 [PMID: 31541420]
  73. Pediatr Neurol. 2020 Aug;109:4-11 [PMID: 32563542]
  74. Mol Autism. 2019 Mar 1;10:9 [PMID: 30867896]
  75. Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):188-97 [PMID: 25989416]
  76. J Intellect Disabil Res. 2015 Apr;59(4):307-18 [PMID: 24965264]
  77. PLoS One. 2019 Oct 17;14(10):e0223162 [PMID: 31622356]
  78. J Autism Dev Disord. 2012 Nov;42(11):2404-9 [PMID: 22527704]
  79. J Autism Dev Disord. 2023 Sep;53(9):3460-3474 [PMID: 35790596]
  80. Adv Autism. 2020 Dec 11;6(4):277-288 [PMID: 38868359]
  81. Am J Intellect Dev Disabil. 2016 Nov;121(6):465-486 [PMID: 27802104]
  82. J Autism Dev Disord. 2019 Jun;49(6):2476-2487 [PMID: 30941551]
  83. J Neurodev Disord. 2019 Jun 7;11(1):6 [PMID: 31174462]
  84. Am J Med Genet A. 2015 Dec;167A(12):2936-44 [PMID: 26331980]
  85. J Autism Dev Disord. 2015 Jul;45(7):1925-37 [PMID: 24414079]
  86. J Neurodev Disord. 2018 Aug 6;10(1):24 [PMID: 30081815]
  87. Minerva Pediatr (Torino). 2021 Jul 26;: [PMID: 34309342]
  88. Orphanet J Rare Dis. 2015 Dec 02;10:154 [PMID: 26631248]
  89. J Autism Dev Disord. 2020 Mar;50(3):719-729 [PMID: 31736004]
  90. Am J Intellect Dev Disabil. 2017 Sep;122(5):359-373 [PMID: 28846036]
  91. J Intellect Disabil Res. 2009 Oct;53(10):852-73 [PMID: 19708861]
  92. Acta Paediatr. 2019 Nov;108(11):2019-2026 [PMID: 31090964]
  93. Psychol Med. 2011 Nov;41(11):2423-33 [PMID: 21426604]
  94. J Cogn Neurosci. 2000;12 Suppl 1:89-107 [PMID: 10953236]
  95. Am J Med Genet B Neuropsychiatr Genet. 2018 Oct;177(7):665-675 [PMID: 30307687]
  96. Res Dev Disabil. 2020 Sep;104:103692 [PMID: 32505083]
  97. Am J Intellect Dev Disabil. 2021 Jan 1;126(1):58-74 [PMID: 33370791]
  98. J Child Psychol Psychiatry. 2017 Jun;58(6):744-747 [PMID: 28524462]
  99. Autism Res. 2022 May;15(5):778-790 [PMID: 35238171]
  100. Annu Rev Public Health. 2007;28:235-58 [PMID: 17367287]
  101. J Intellect Disabil Res. 2020 Feb;64(2):158-169 [PMID: 31849130]
  102. J Autism Dev Disord. 2022 Mar;52(3):1235-1246 [PMID: 33905067]
  103. Res Dev Disabil. 2013 May;34(5):1642-55 [PMID: 23475013]
  104. Front Psychol. 2022 Jul 29;13:927847 [PMID: 35967726]
  105. Schizophr Res. 2017 Oct;188:59-62 [PMID: 28119035]
  106. J Neurodev Disord. 2011 Sep;3(3):225-37 [PMID: 21858456]
  107. Autism Res. 2014 Aug;7(4):433-41 [PMID: 24664986]
  108. J Neurodev Disord. 2018 Mar 1;10(1):9 [PMID: 29490614]
  109. J Intellect Disabil Res. 2016 Nov;60(11):1097-1108 [PMID: 27109005]
  110. Front Psychiatry. 2019 May 07;10:199 [PMID: 31133885]
  111. J Autism Dev Disord. 2017 Dec;47(12):3741-3755 [PMID: 28210826]
  112. Nat Rev Genet. 2018 Oct;19(10):649-666 [PMID: 29995837]
  113. Am J Intellect Dev Disabil. 2014 May;119(3):235-52 [PMID: 24871792]
  114. Mol Autism. 2023 Jan 13;14(1):3 [PMID: 36639821]
  115. Front Psychiatry. 2019 Jul 30;10:526 [PMID: 31417436]
  116. Ann Clin Transl Neurol. 2020 Aug;7(8):1371-1381 [PMID: 32705817]
  117. Am J Med Genet A. 2015 Dec;167A(12):2945-56 [PMID: 26418839]
  118. Res Dev Disabil. 2014 Jul;35(7):1742-7 [PMID: 24656292]
  119. J Intellect Disabil Res. 2021 Jul;65(7):666-674 [PMID: 33951249]
  120. J Intellect Disabil Res. 2022 Mar;66(3):265-281 [PMID: 34984734]
  121. Front Genet. 2014 Oct 16;5:355 [PMID: 25360144]
  122. J Intellect Disabil Res. 2018 Aug;62(8):672-683 [PMID: 29722449]
  123. Psychiatry Res. 2021 May;299:113851 [PMID: 33735741]

Word Cloud

Created with Highcharts 10.0.0syndromesautismAutismcharacteristicsdisabilityGeneticgeneticintellectualbehaviouralKeyassessmentsupportspecificityphenotypesegwithinHeterogeneityPurposeReview:Elevatedprevalencereportedassociatedreviewsummarisesrecentevidenceheterogeneityfollowingsyndromes:FragileXCorneliadeLangeWilliamsPrader-WilliAngelmanSmith-MagenistuberoussclerosiscomplexconsiderationsdiscussedRecentFindings:profiledevelopmentaltrajectoryautism-relatedbehaviourindicatedegreesyndromemayinteractbroaderhypersociabilitymentalhealthanxietysubtypeco-occurringepilepsycontributeincreasedsignificanceAutism-relatedstrengthschallengeslikelyoverlookedmisunderstoodusingexistingscreening/diagnostictoolscriterialacksensitivitypopulationsSummary:highlyheterogeneousacrossoftendistinguishablenon-syndromicdiagnosticpracticespopulationtailoredspecificServiceprovisionsmustbeginprioritiseneeds-ledCharacteristicsSyndromes:ConsiderationsAssessmentSupportBehaviouralCo-occurrenceIntellectual

Similar Articles

Cited By